AAL
62
3
MSI
58
-5
DHI
45
-2
KR
56
11
JCI
47
-4
FITB
46
-2
DLTR
54
3
MLM
44
-3
PPG
64
-4
QRVO
9
-2
NOV
40
-2
BBY
46
3
ORCL
59
-3
SE
58
-3
EFX
44
-5
GD
41
2
SYY
50
-3
HAL
39
2
AIZ
64
-4
DE
56
-2
AAL
62
3
MSI
58
-5
DHI
45
-2
KR
56
11
JCI
47
-4
FITB
46
-2
DLTR
54
3
MLM
44
-3
PPG
64
-4
QRVO
9
-2
NOV
40
-2
BBY
46
3
ORCL
59
-3
SE
58
-3
EFX
44
-5
GD
41
2
SYY
50
-3
HAL
39
2
AIZ
64
-4
DE
56
-2
Financhill
Back

Soleno Therapeutics 10K Form

Buy
60

SLNO
Soleno Therapeutics

Last Price:
47.47
Seasonality Move:
42.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SLNO News And Ratings

See the #1 stock for the next 7 days that we like better than SLNO

SLNO Financial Statistics

Sales & Book Value

Annual Sales: $387.56K
Cash Flow: $-15.12M
Price / Cash Flow: 0
Annual Sales: $6.45
Price / Book: 7.71

Profitability

EPS (TTM): -3.34660
Net Income (TTM): $-131.16M
Gross Margin: $34.87K
Return on Equity: 0%
Return on Assets: 0%

Soleno Therapeutics Earnings Forecast

Key Soleno Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 2 years for SLNO is 9.00%.
  • The Selling, General & Administrative Expenses for SLNO have been equal to 2,032.79% of Gross Profit Margin.
  • The Interest Expense is -3.83% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 9 years.

Soleno Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SLNO
CUSIP: 834203
Website: soleno.life

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SLNO Technical Analysis vs Fundamental Analysis

Buy
60
Soleno Therapeutics (SLNO) is a Buy

Is Soleno Therapeutics a Buy or a Sell?